AIG
PRDS

American International Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

American International Group’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,571
Closed -$21.9K – 3228
2023
Q1 		$21.9K Buy
16,571
+330
+2% +$540 ﹤0.01% 2882
2022
Q4 		$27.4K Sell
16,241
-59
-0.4% -$75 ﹤0.01% 2880
2022
Q3 		$30K Buy
16,300
+3,038
+23% +$9.06K ﹤0.01% 2937
2022
Q2 		$41K Buy
+13,262
New +$81K ﹤0.01% 2917

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

American International Group's PRDS Position: Q2 2023 in Review

American International Group sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q2 2023, closing a stake of 16,571 shares — an estimated $21.9K sold.

American International Group first reported a position in PRDS in Q2 2022 and held it in 4 quarters. The position peaked at $41K in Q2 2022. 59 funds tracked by Wall St. Rank hold PRDS as of Q2 2023.

  • American International Group reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 16,571 Pardes Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $21.9K.
  • American International Group first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • American International Group's Pardes Biosciences, Inc. Common Stock position peaked at $41K in Q2 2022.
  • 59 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.